Hong Kong: MSF assesses and supports elderly homes and residential care homes for persons with disabilities to cope with potential future outbreaks
8-8 | Since March 2022, an MSF – Hong Kong team with doctors, nurses, psychologists, and engineers, has conducted multi-disciplinary assessments in 16 elderly homes and residential care homes for persons with disabilities to cope with potential future outbreaks. The team has provided key recommendations on ventilation and air quality, infection and prevention control, as well as mental health and emotional well-being of the residents and staff.
5-4 | The COVID-19 vaccine Humanitarian Buffer (HB) is failing its mission to support people hit by the pandemic and struggling to access immunisation, says Médecins Sans Frontières (MSF). The HB is part of the COVAX mechanism*, whose aim is to assist groups of people who do not have access to COVID-19 vaccination in situations of humanitarian emergency. However, MSF’s recent experience in northern Syria has highlighted the system’s limitations and ultimate failure to fulfil its purpose.
2-17 | CAPE TOWN - A vaccination support programme developed by MSF in Khayelitsha, South Africa, in partnership with the Western Cape Department of Health (WCDoH), has shown that it is possible to target and protect individuals with comorbidities that increase the risk of severe disease and death from COVID-19.
1-5 | Myanmar’s public healthcare system is in disarray. Days after the military seized power on 1 February, medical staff walked out of their jobs, spearheading the civil disobedience movement that saw government employees of all stripes go on strike. Most have not returned. Those on strike who continue to practice in underground clinics risk being attacked and detained by the authorities. At least 28 healthcare professionals have been killed since 1 February, and nearly 90 remain arrested.
As Moderna releases astronomical Q3 sales figures, MSF tells the corporation it’s high time to share the technology with WHO mRNA vaccine tech transfer Hub in South Africa
11-4 | Following the release of US pharmaceutical company Moderna’s astronomical third quarter 2021 sales figures from its only product, the COVID-19 vaccine, Médecins Sans Frontières/Doctors Without Borders (MSF) urged the company to immediately share its mRNA vaccine technology and know-how through the World Health Organization's (WHO) COVID-19 mRNA vaccine technology transfer Hub in South Africa.